Adempas
riociguat
- Strength
- .5 mg/1
- Form
- Tablet, Film Coated
- Class
- Soluble Guanylate Cyclase Stimulator
Bayer HealthCare Pharmaceuticals Inc.
riociguat
Listed by Bayer HealthCare Pharmaceuticals Inc.
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Soluble Guanylate Cyclase Stimulator |
| Approval route | NDA — original brand approval |
| NDC code | 50419-252 |
| FDA application | NDA204819 |
| Package sizes listed | 3 |
| Marketed since | October 2013 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
riociguat
Bayer HealthCare Pharmaceuticals Inc.
riociguat
Bayer HealthCare Pharmaceuticals Inc.
riociguat
Bayer HealthCare Pharmaceuticals Inc.
riociguat
Bayer HealthCare Pharmaceuticals Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.